Chao H S, Myers S E, Handwerger S
Division of Endocrinology, Children's Hospital Medical Center, Cincinnati, Ohio 45229-2899.
Endocrinology. 1993 Aug;133(2):505-10. doi: 10.1210/endo.133.2.8344196.
Recent studies have shown that the basal release of PRL from anterior pituitary cells is inhibited by endothelin-1 (ET-1) and ET-3. To determine whether ET also regulates the synthesis and release of PRL by decidual cells, we examined the effects of ET on the synthesis and release of PRL from an enriched fraction of human decidual cells prepared by isopycnic centrifugation of enzymatically dispersed term decidual tissue. Exposure of decidual cells to ET-1 (10(-7) M) for 96 h caused a progressive decrease in basal PRL synthesis and release beginning 24 h after exposure with half-maximal inhibition occurring at an ET-1 concentration of 5 x 10(-9) M. Between 72-96 h of culture, ET-1-exposed cells synthesized 37.2 +/- 2.7% (SEM) and released 32.3 +/- 1.3% less PRL than control cells (P < 0.01). ET-1-exposed cells incubated with [35S]methionine between 72-96 h also released less [35S] PRL than control cells. Sarafotoxin S6C, an ETB receptor agonist, also inhibited basal PRL release, whereas BQ-123, an ETA receptor antagonist, had no effect on basal or on ET-1-mediated inhibition of PRL release. ET-1 also markedly inhibited the stimulation of PRL synthesis and release in response to insulin and insulin-like growth factor-1 (IGF-1). Cells exposed to insulin (100 ng/ml) and IGF-1 (50 ng/ml) alone released 61.2 +/- 3.6% and 40.0 +/- 3.8% more PRL, respectively, than control cells between 72-96 h of exposure. However, cells exposed simultaneously to insulin and ET-1 (10(-7) M) released only 17.1 +/- 3.5% more PRL than control cells during the same time period, and cells exposed simultaneously to IGF-1 and ET-1 released only 4.1 +/- 1.8% more PRL than controls during the same time interval (P vs. insulin or IGF-1 alone < 0.001 in each instance). Both basal and insulin- and IGF-1-stimulated PRL release were also inhibited by the ET isotypes ET-2 and ET-3, and by the ET-1 precursor, big ET. Since macrophages and decidual cells synthesize ET, and decidual tissue contains specific receptors for ET, the inhibitory action of ET on basal and stimulated PRL release may result from an autocrine and/or paracrine effect and appears to be mediated through the ETB receptor.
近期研究表明,内皮素-1(ET-1)和内皮素-3可抑制垂体前叶细胞基础状态下催乳素(PRL)的释放。为确定ET是否也调节蜕膜细胞PRL的合成与释放,我们通过对足月分娩时酶解分散的蜕膜组织进行等密度离心,制备了富含人蜕膜细胞的组分,研究了ET对该组分中PRL合成与释放的影响。将蜕膜细胞暴露于ET-1(10⁻⁷ M)96小时,自暴露后24小时起基础PRL合成与释放逐渐减少,在ET-1浓度为5×10⁻⁹ M时出现半数最大抑制。在培养72 - 96小时期间,暴露于ET-1的细胞合成的PRL比对照细胞少37.2±2.7%(标准误),释放的PRL比对照细胞少32.3±1.3%(P < 0.01)。在72 - 96小时期间用[³⁵S]甲硫氨酸孵育的暴露于ET-1的细胞释放的[³⁵S]PRL也比对照细胞少。ETB受体激动剂色拉毒素S6C也抑制基础PRL释放,而ETA受体拮抗剂BQ-123对基础PRL释放或ET-1介导的PRL释放抑制无影响。ET-1还显著抑制对胰岛素和胰岛素样生长因子-1(IGF-1)的反应中PRL的合成与释放。在暴露72 - 96小时期间,单独暴露于胰岛素(100 ng/ml)和IGF-1(50 ng/ml)的细胞分别比对照细胞多释放61.2±3.6%和40.0±3.8%的PRL。然而,在同一时间段,同时暴露于胰岛素和ET-1(10⁻⁷ M)的细胞比对照细胞仅多释放17.1±3.5%的PRL,同时暴露于IGF-1和ET-1的细胞在同一时间间隔比对照细胞仅多释放4.1±1.8%的PRL(每种情况与单独的胰岛素或IGF-1相比P < 0.001)。ET同型物ET-2和ET-3以及ET-1前体大ET也抑制基础以及胰岛素和IGF-1刺激的PRL释放。由于巨噬细胞和蜕膜细胞合成ET,且蜕膜组织含有ET的特异性受体,ET对基础和刺激的PRL释放的抑制作用可能源于自分泌和/或旁分泌效应,且似乎是通过ETB受体介导的。